Funding · Company
Pacegenix, Inc.
Cambridge, MABiotech & Pharma
Pacegenix, Inc. of Cambridge, MA has disclosed $23M across 1 Form D offering filed with the SEC on Mar 26, 2026.
$23M
Total disclosed
1
Form D offering
2024
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
Filing details
HeadquartersCambridge, MAIndustryBiotech & Pharma (Biotechnology)Incorporated2024SEC CIK0002117706Offerings on file1
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →